Patient & Visitor InformationContact Us
  • Meet the Team

  • The Comprehensive Cancer Center
    Radiation Oncology

    Meet the Team

    Jaroslaw Hepel, MD

    HepelJaroslaw Hepel, MD is an assistant professor in the department of radiation oncology at Brown University and adjunct assistant professor at Tufts University. He is board certified in radiation oncology by the American Board of Radiology and in internal medicine by the American Board of Internal Medicine. He currently serves as director of the Rhode Island Hospital Stereotactic Radiotherapy and Radiosurgery Program and is associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. Hepel recently joined the radiation oncology department at Rhode Island Hospital in the Summer of 2010.

    Hepel received his undergraduate degree at Cornell University in 1997 with distinction in all subjects. He earned his medical degree at the University of Rochester in 2001, and then completed an internal medicine residency at the University of California Irvine Medical Center. He then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA where he had the honor of serving as chief resident.

    Hepel has broad training and knowledge, and is active in caring for patients with a broad range of malignant diseases. He holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the brain, spine, lung, liver and other sites. He has published several scientific papers in these areas and has presented his work at national meetings. He has authored two book chapters on accelerated partial breast irradiation (APBI). He continues to be active in research in the areas of breast cancer, stereotactic radiosurgery/radiotherapy and new technologies.

    Hepel is a member of the American Society of Therapeutic Radiology and Oncology, American College of Radiology, the American College of Radiation Oncology and the American Society of Clinical Oncology.